Konapharma limited company (Ltd.) is a privately owned Swiss CMO (Contract Manufacturing Organization) focused on the production of solid dosage forms specialized in “difficult to produce” as MUPS (Multi unit pellet systems) tablets and other retard forms and bi-layered tablets. In addition, Konapharma Ltd. holds a special permit to handle and process controlled substances like narcotics. In blistering and packaging Konapharma Ltd. is offering high volume blistering but also “difficult to pack” services for special packaging needs (inhalation capsules, vials) and hard gelatin capsule filling with 100% control. In total Konapharma Ltd. offers two bulk production, as well as two primary and secondary packaging units operating all on the same site. The company site has a total floor area of 15,570 m2.
| Website | http://www.konapharma.ch |
| Revenue | $5.9 million |
| Employees | 75 (49 on RocketReach) |
| Founded | 1989 |
| Address | Im Wannenboden 16, Pratteln, Basel-Landschaft 4133, CH |
| Phone | +41 61 816 20 40 |
| Technologies |
JavaScript
,
HTML
,
Polyfill
+4 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Multi Units Pellets System, Narcotics, Bi-layered tablets, High Speed Blistering, Low Rh Blistering (9%-15%), Wallet packaging, Alu/Alu blistering |
| Competitors | Roche, Novartis, AbbVie, Pfizer, Sanofi, Bayer, GSK, AstraZeneca, Merck Group, Lilly India +52 more (view full list) |
Looking for a particular Konapharma Ltd. employee's phone or email?
The Konapharma Ltd. annual revenue was $5.9 million in 2026.
Christoph Staub is the CEO of Konapharma Ltd..
49 people are employed at Konapharma Ltd..
Konapharma Ltd. is based in Pratteln, Basel-Landschaft.